These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 903324)

  • 1. Pharmacokinetics of cefazolin patients with normal and impaired renal function.
    Bergan T; Brodwall EK; Orjavik O
    J Antimicrob Chemother; 1977 Sep; 3(5):435-43. PubMed ID: 903324
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption, distribution and elimination of cefazolin in patients with normal renal function.
    Bergan T; Digranes A; Schreiner A
    Chemotherapy; 1978; 24(5):277-82. PubMed ID: 352636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transport of cefazolin in normal and impaired renal function.
    Brodwall EK; Bergan T; Orjavik O
    J Antimicrob Chemother; 1977 Nov; 3(6):585-92. PubMed ID: 599121
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration.
    Bergan T
    Chemotherapy; 1977; 23(6):389-404. PubMed ID: 923329
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
    Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.
    Rattie ES; Ravin LJ
    Antimicrob Agents Chemother; 1975 May; 7(5):606-13. PubMed ID: 1147591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.
    Harvengt C; Muenier H; Lamy F
    J Clin Pharmacol; 1977; 17(2-3):128-33. PubMed ID: 833342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
    Philipson A; Stiernstedt G; Ehrnebo M
    Clin Pharmacokinet; 1987 Feb; 12(2):136-44. PubMed ID: 3829560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long half-life for cefazolin in anuria.
    Moore TD; Seth SK
    Ann Intern Med; 1978 Feb; 88(2):269-70. PubMed ID: 626466
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP; Rifkin SI
    Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftezole in patients with normal and impaired renal function.
    Ohkawa M; Kuroda K
    Chemotherapy; 1980; 26(4):242-7. PubMed ID: 7389424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue levels of "cefazolin" in man after parenteral administration (author's transl).
    Cimmino PT; Garaci E
    Antibiotica; 1973 Mar; 11(1):31-44. PubMed ID: 4619551
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory studies on cefazolin--anti-inflammatory agent combinations with particular reference to tiaramide.
    Shimizu T
    Jpn J Antibiot; 1974 Dec; 27(6):725-9. PubMed ID: 4219031
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of cefazolin in horses.
    Sams RA; Ruoff WW
    Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.
    Polk RE; Smith JE; Ducey K; Lower RR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):201-3. PubMed ID: 6927281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic studies of cephalothin, cefazolin and cefmetazole in the neonates and the premature babies.
    Sakata Y
    Kurume Med J; 1980; 27(4):275-98. PubMed ID: 6946258
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in pharmacokinetics of cefazolin due to stress.
    Nightingale CH; Bassaris H; Tilton R; Quintiliani R
    J Pharm Sci; 1975 Apr; 64(4):712-4. PubMed ID: 1142091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.